Disease: Prurigo nodularis
- [Translated article] Prurigiform Angiomatosis: A New Term for Describing the Prominent Dermal Angiomatoid Proliferation Underlying Epidermal Changes in Prurigo Nodularis/Lichen Simplex Chronicus
- <em>Staphylococcus aureus</em> proteases trigger eosinophil-mediated skin inflammation
- "Outside-to-inside," "inside-to-outside," and "intrinsic" endogenous pathogenic mechanisms in atopic dermatitis: keratinocytes as the key functional cells involved in both permeability barrier dysfunction and immunological al
- A case of bullous pemphigoid following administration of anti-IL-31 receptor A antibody
- A Case of Prurigo Nodularis Associated With Crohn's Disease Responding to Upadacitinib
- A Case of Superficial Papular Neuroma: A Rare Neural Neoplasm
- A case-control study addressing the population of epidermal and dermal inflammatory infiltrate including neural milieu in primary prurigo nodularis using S-100 and toluidine blue stain and its therapeutic implications
- A critical evaluation of nemolizumab for prurigo nodularis
- A critical review of dupilumab for adult patients with prurigo nodularis
- A randomized, double-blinded, vehicle-controlled clinical trial of topical cryosim-1, a synthetic TRPM8 agonist, in prurigo nodularis
- A systematic review of interleukin-31 inhibitors in the treatment of prurigo nodularis
- Angiomatosis prurigiforme: una nueva entidad propuesta para la proliferacion angiomatoide dermica prominente subyacente a los cambios epidermicos de prurigo nodularis/liquen simple cronico
- Association between prurigo nodularis and behavioural patterns of attention-deficit/hyperactivity disorder in children with atopic dermatitis: A cross-sectional study
- Baseline eosinophil level may be a predictive indicator for the effectiveness of dupilumab in patients with prurigo nodularis: A single-center, real-world prospective study
- Baseline eosinophil level may be a predictive indicator for the effectiveness of Dupilumab in patients with prurigo nodularis: A single-center, real-world prospective study in China
- Characterization of Paediatric Prurigo Nodularis: A Multicentre Retrospective, Observational Study
- Cholestatic Pruritus Mimicking a Cutaneous Drug Eruption
- Chronic prurigo
- Chronic Prurigo Including Prurigo Nodularis: New Insights and Treatments
- Clinical and Temporal Characteristics of Malignancy-Associated Prurigo Nodularis: A Systematic Review
- Clinical Characteristics and Treatment Outcomes of Prurigo Nodularis: A Retrospective Study
- Clinical spectrum of DOCK8 deficiency from a tertiary care center in North India
- Clinical utility of peripheral blood laboratory testing in the diagnostic workup of prurigo nodularis: A multicenter cohort study
- Comorbidities of prurigo nodularis in Chinese patients: A multicenter retrospective study
- Comorbidities, healthcare resource utilization & treatment pattern among patients with prurigo nodularis, compared to a benchmark in Germany: A real-world evidence claims data study
- Comparing the efficacy of updated treatment choices for prurigo nodularis: A network meta-analysis
- Comparison between dupilumab and oral Janus kinase inhibitors in the treatment of prurigo nodularis with or without atopic dermatitis in a tertiary care center in Singapore
- Comprehensive plasma cytokine and chemokine profiling in prurigo nodularis reveals endotypes in Type 2 inflammation
- Consensus document on the diagnostic algorithm for chronic nodular prurigo
- Deciphering the enigma of itch sensation: insights and impact from a readability study
- Dermoscopy to differentiate clinically similar inflammatory and neoplastic skin lesions
- Development and Validation of a Patient-Reported Outcome Measure to Assess Disease Control in Chronic Prurigo
- Disease burden and treatment satisfaction in patients with prurigo nodularis in Japan
- Dupilumab as a novel treatment option for prurigo nodularis
- Dupilumab bei einem 5-jährigen Kind mit Prurigo nodularis
- Dupilumab effectiveness in a case of prurigo nodularis and severe recalcitrant hidradenitis suppurativa
- Dupilumab for a 5-year-old child with prurigo nodularis
- Dupilumab for the Treatment of Prurigo Nodularis
- Dupilumab for Treatment of Prurigo Nodularis: Real-Life Effectiveness for up to 84 Weeks
- Dysregulation of the Skin-Liver Axis in Prurigo Nodularis: An Integrated Genomic, Transcriptomic, and Population-Based Analysis
- Editorial: Cutaneous immunology
- Effectiveness of Dupilumab for Chronic Prurigo in Chinese Patients: A Real-World Case Series Study
- Efficacy and safety of nemolizumab and topical corticosteroids for prurigo nodularis: Results from a randomised, double-blind, placebo-controlled, phase II/III clinical study in patients aged 13 years
- Estimating meaningful change thresholds for Skin Pain-Numeric Rating Scale, Sleep-Numeric Rating Scale and Dermatology Life Quality Index in patients with prurigo nodularis
- Evaluating the Clinical Meaning of Dermatology Life Quality Index Scores Between Different Phenotypes of Atopic Dermatitis in Patients Before and After Biologic Therapy With Dupilumab
- Evaluation of the histopathological spectrum of skin biopsies in patients with chronic kidney disease: A single-center experience
- HIV-related exclusion criteria in atopic dermatitis and prurigo nodularis clinical trials
- Incident Comorbidity, Resource Use, and All-Cause Mortality Associated with Prurigo Nodularis: A United Kingdom Retrospective Database Analysis
- Increased cardiovascular risks and mortality in prurigo nodularis: a global cohort study
- INDIVIDUAL ARTICLE: Management of Prurigo Nodularis
- INDIVIDUAL ARTICLE: New Horizons in Our Understanding of Prurigo Nodularis and Its Management
- INDIVIDUAL ARTICLE: Patient Journey and the Burden of Systemic Comorbidities and Sequalae in Prurigo Nodularis
- INDIVIDUAL ARTICLE: Prurigo Nodularis: Current Clinicopathologic Overview and Psychodermatological Perspectives
- Janus Kinase Inhibition in the Treatment of Prurigo Nodularis
- Kappa opioid agonists in the treatment of itch: just scratching the surface?
- Kelch-like Protein-11 Encephalitis Associated With Squamous Cell Carcinoma of Unknown Origin: A Case Report
- Learning from nemolizumab: A promising therapy for prurigo nodularis
- Learnings from Nemolizumab: A Promising Therapy for Prurigo Nodularis
- Long-term therapeutic response to dupilumab in patients affected by prurigo nodularis: A real-world retrospective study
- Mechanism underlying pruritus in recessive dystrophic epidermolysis bullosa: Role of interleukin-31 from mast cells and macrophages
- Molecular mechanisms of pruritus in prurigo nodularis
- Neuroimmune interplay during type 2 inflammation: symptoms, mechanisms and therapeutic targets in atopic diseases
- New insight into prurigo nodularis: Proadrenomedullin N-terminal 20 peptide mediates mouse mast cell activation via Mrgprb2
- New insight into the role of fibroblasts in the epithelial immune microenvironment in the single-cell era
- New Laser Treatment for Prurigo Nodularis
- Non-Systemic Medication for the Treatment of Prurigo Nodularis: A Systematic Review
- Patient Perspectives on Living With Severe Prurigo Nodularis
- Phase 3 Trial of Nemolizumab in Patients with Prurigo Nodularis
- Prevalence of malignancy and associated risk factors in prurigo nodularis patients: a retrospective study
- Prevalence of prurigo nodularis in Sweden
- Prurigiform Angiomatosis: A New Term for Describing the Prominent Dermal Angiomatoid Proliferation Underlying Epidermal Changes in Prurigo Nodularis/Lichen Simplex Chronicus
- Prurigo nodularis following the lines of blaschko - A case of superimposed segmental manifestation
- Prurigo nodularis forecast: light Th2 inflammation, with high chances of fibrosis
- Prurigo nodularis forecast: Light type 2 inflammation with high chances of fibrosis
- Prurigo nodularis-A case report
- Prurigo nodularis: A "Cinderella" disease with significant burden and a bright future
- Prurigo Nodularis: Moving Forward
- Prurigo Nodularis: New insights into pathogenesis and novel therapeutics
- Psychopathology Associated with Chronic Pruritus: A Systematic Review
- Retraction: Abnormal plasma levels of steroids and their ratios in patients with prurigo nodularis: a pilot study
- Risk of atopic dermatitis and the atopic march paradigm in children of mothers with atopic illnesses: A birth cohort study from the United Kingdom
- Risk of incident sleep disorders in patients with prurigo nodularis: A population-level analysis using The Health Improvement Network
- Severity, impact on quality of life and mental health burden of pruritus in prurigo nodularis: a cross-sectional study of a diverse patient cohort
- Single-cell RNA sequencing reveals dysregulated POSTN+WNT5A+ fibroblast subclusters in prurigo nodularis
- Somatic mutations reveal hyperactive Notch signaling and racial disparities in prurigo nodularis
- Spatial mass cytometry-based single cell imaging reveals a disrupted epithelial-immune axis in prurigo nodularis
- Successful treatment of refractory prurigo nodularis with abrocitinib
- Successful Treatment of Refractory Prurigo Nodularis with Alitretinoin and Methotrexate Combination Therapy
- Systemic Medication for the Treatment of Prurigo Nodularis-A Systematic Review
- The top 100 most cited contributions on prurigo nodularis: A bibliometric analysis
- The top 100 most cited contributions on prurigo nodularis: A bibliometric analysis
- The top 100 most cited publications on Prurigo Nodularis: a bibliometric analysis
- The top 100 most cited publications on Prurigo Nodularis: a bibliometric analysis
- Treatment of chronic prurigo with upadacitinib: a case series
- Treatment of recalcitrant paediatric prurigo nodularis with tofacitinib, an exquisite example of bench-to-bedside translation of JAK-STAT expression
- Unraveling the Enigma of Perforating Itches: A Comprehensive Report of Reactive Perforating Collagenosis in Three Patients
- Upadacitinib for moderate to severe atopic dermatitis with generalized prurigo nodularis
- Validation of a scoring algorithm for the clinician-reported outcome tool 'prurigo activity and severity (PAS)' based on clinical studies of dupilumab in adults with prurigo Nodularis
- Validation of the Peak Pruritus Numerical Rating Scale as a Patient-Reported Outcome Measure in Prurigo Nodularis
- When Multiple Conditions Converge: An Unusual Case of Infectious Aortitis in a Patient With Prurigo Nodularis and an Abdominal Aortic Aneurysm Endograft